Showing results (111-120 of 126) with videos related to
Sort By:
Pageof 13
International Journal of Cancer|January 18, 2019
Combined targeted DNA and RNA sequencing of advanced NSCLC in routine molecular diagnostics: Analysis of the first 3,000 Heidelberg casesAnna-Lena Volckmar, Jonas Leichsenring, Martina Kirchner, et al.Gastroenterology|November 17, 2018
Nuclear Translocation of RELB Is Increased in Diseased Human Liver and Promotes Ductular Reaction and Biliary Fibrosis in MiceChristin Elßner, Benjamin Goeppert, Thomas Longerich, et al.Liver International : Official Journal of the International Association for the Study of the Liver|August 21, 2024
Lymphotoxin beta-activated LTBR/NIK/RELB axis drives proliferation in cholangiocarcinomaKaiyu Xu, Annika Kessler, Federico Nichetti, et al.Hepatology (Baltimore, Md.)|November 24, 2016
Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort studyElisabeth M G de Vries, Manon de Krijger, Martti Färkkilä, et al.Cancer Discovery|July 20, 2021
Genetic Screens Identify a Context-Specific PI3K/p27Kip1 Node Driving Extrahepatic Biliary CancerChiara Falcomatà, Stefanie Bärthel, Angelika Ulrich, et al.Cell Death & Disease|October 18, 2020
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancerAnna-Lena Scherr, Andreas Mock, Georg Gdynia, et al.Annals of Surgical Oncology|June 19, 2024
Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized DiseaseAnne-Marleen van Keulen, Stefan Buettner, Pim B Olthof, et al.Hepatology (Baltimore, Md.)|January 12, 2020
Genomic Characterization of Cholangiocarcinoma in Primary Sclerosing Cholangitis Reveals Therapeutic OpportunitiesBenjamin Goeppert, Trine Folseraas, Stephanie Roessler, et al.Nature Reviews. Gastroenterology & Hepatology|February 9, 2023
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevanceDiego F Calvisi, Luke Boulter, Javier Vaquero, et al.Nature Reviews. Gastroenterology & Hepatology|December 10, 2025
Cholangiocarcinoma 2026: status quo, unmet needs and prioritiesJesus M Banales, Pedro M Rodrigues, Silvia Affò, et al.Pageof 13